Dr. Lewis H Rosenbaum is a Royal Oak, Michigan based male rheumatologist who is specialized in Rheumatology. Active license number of Dr. Lewis H Rosenbaum for Rheumatology is 4301039781 in Michigan. Dr. Lewis H Rosenbaum treat joint disease similar to orthopedists but do not perform surgeries. He diagnose and treat diseases of joints, muscle, bones and tendons which includes arthritis, back pain, muscle strains, common athletic injuries and 'collagen' diseases.
Complete Profile:
Dr. Lewis H Rosenbaum speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Rheumatology
Credentials:
MD
Gender:
Male
Practice Address:
3535 W 13 Mile Rd, Suite 140, Royal Oak, Michigan, 48073-6710
Phone:
248-551-7009
Fax:
248-551-2204
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1972571552
NPI Enumeration Date:
09 Mar, 2006
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Lewis H Rosenbaum are as mentioned below.
License Number
Specialization
State
Status
4301039781
Rheumatologist
Michigan
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
4384 Pinehurst Dr, West Bloomfield, Michigan
Zip:
48322-4475
Phone Number:
248-932-0255
Fax Number:
248-932-5626
Patients can reach Dr. Lewis H Rosenbaum at 3535 W 13 Mile Rd, Suite 140, Royal Oak, Michigan or can call to book an appointment on 248-551-7009. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.